Clinical Trials Browser

Bone Neoplasms, Chondrosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT04055220 2026-02-17

REGOSTA

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

NCT06387485 2026-02-06

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Phase NA Recruiting

150 enrolled

Sarcoma

Chondrosarcoma, Fibrosarcoma, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Benign Fibrous

NCT05779670 2026-02-03

ADER

Recruiting

50 enrolled

Sarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT05861245 2026-01-23

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

Phase NA Recruiting

20 enrolled

Sarcoma

Chondrosarcoma, Chordoma

NCT07315542 2026-01-05

Diagnostic and Therapeutic Targets in Cartilaginous Tumours

Recruiting

300 enrolled

Sarcoma

Chondrosarcoma

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

32 enrolled

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT06176989 2025-10-20

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

Phase 2 Recruiting

40 enrolled

CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT05039801 2025-10-14

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Phase 1 Recruiting

54 enrolled

DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

NCT04040205 2025-07-20

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Phase 2 Recruiting

44 enrolled

Other solid neoplasmSarcoma

Chondrosarcoma, Retinoblastoma, Sarcoma, Osteosarcoma

NCT04087902 2025-07-03

Long-Term Longitudinal QoL in Patients Undergoing EEA

Recruiting

400 enrolled

CNSEndocrineSarcoma

Chondrosarcoma, Chordoma, Craniopharyngioma, Encephalocele, Meningioma, Pituitary Neoplasms, Esthesioneuroblastoma, Olfactory, Central Nervous System Cysts

NCT06029218 2024-09-25

P1V2

Phase NA Recruiting

106 enrolled

Sarcoma

Chondrosarcoma, Chordoma, Sarcoma, Ewing, Osteosarcoma

NCT04832620 2023-11-18

CHIPT

Recruiting

40 enrolled

Sarcoma

Chondrosarcoma, Chordoma

NCT05193188 2023-02-16

A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma

Phase 2 Recruiting

70 enrolled

Sarcoma

Chondrosarcoma

Clinical Trials

Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas

REGOSTA

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

ADER

Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base

Diagnostic and Therapeutic Targets in Cartilaginous Tumours

VARTUTRACE

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Long-Term Longitudinal QoL in Patients Undergoing EEA

P1V2

CHIPT

A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma